![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Cheong Y, Sadek K, Watson A, Metwally M, Li TC. 2011. Adhesion reduction agents in gynaecological procedures: can NHS afford it? An economic cost efficiency analysis. Journal of Obstetrics and Gynaecology 31:631–635.
- Dawood AS, Elgergawy AE. 2018. Incidence and sites of pelvic adhesions in women with post-caesarean infertility. Journal of Obstetrics and Gynaecology 38:1158–1163.
- Gomel V, Koninckx PR. 2016. Microsurgical principles and postoperative adhesions: lessons from the past. Fertility and Sterility 106:1025–1031.
- Han ES, Scheib SA, Patzkowsky KE, Simpson K, Wang KC. 2017. The sticky business of adhesion prevention in minimally invasive gynecologic surgery. Current Opinion in Obstetrics & Gynecology 29:266–275.
- Korell M, Ziegler N, De Wilde RL. 2016. Use of modified polysaccharide 4DryField (®) PH for adhesion prevention and hemostasis in gynecological surgery: a two-center observational study by second-look laparoscopy. BioMed Research International 2016:3029264.
- PlantTec Medical, Bad Bevensen, Germany. 2019. 4DryField® PH Instructions for use. [cited 2019 Jun 26] Available from: https://www.planttec-medical.de/wp-content/uploads/instructions-for-use_7.5-3-28_rev.1.0.pdf.
- Poehnert D, Abbas M, Kreipe HH, Klempnauer J, Winny M. 2015b. Evaluation of 4DryField® PH as adhesion prevention barrier tested in an optimized adhesion model in rats. European Surgical Research 55:341–351.
- Poehnert D, Abbas M, Maegel L, Sambale F, Lavrentieva A, Kreipe HH, et al. 2015a. Evaluation of the biological tolerability of the starch-based medical device 4DryField® PH in vitro and in vivo a rat model. Journal of Biomaterials Applications 30:463–471.
- Poehnert D, Grethe L, Maegel L, Jonigk D, Lippmann T, Kaltenborn A, et al. 2016. Evaluation of the effectiveness of peritoneal adhesion prevention devices in a rat model. International Journal of Medical Sciences 13:524–532.
- Spotnitz WD, Burks S. 2012. Hemostats, sealants, and adhesives III: a new update as well as cost and regulatory considerations for components of the surgical toolbox. Transfusion 52:2243–2255.
- Watrowski R. 2014. Hemostatic gelatine-thrombin matrix (Floseal®) facilitates hemostasis and organ preservation in laparoscopic treatment of tubal pregnancy. Archives of Gynecology and Obstetrics 290:411–415.
- Watrowski R, Jäger C, Forster J. 2017. Improvement of perioperative outcomes in major gynecological and gynecologic-oncological surgery with hemostatic gelatin-thrombin matrix. In Vivo (Athens, Greece) 31:251–258.
- Winny M, Maegel L, Grethe LV, Jonigk D, Borchert P, Kaltenborn A, et al. 2016. Treatment of de-peritonealized intestine with 4DryField® PH prevents adhesions between non-resorbable intra-peritoneal hernia mesh and bowel. Americal Journal of Translational Research 8:5706–5714.